Home > Healthcare > Biotechnology > Biopharma > Monoclonal Antibodies Market
Monoclonal Antibodies Market Size
- Report ID: GMI5065
- Published Date: Jul 2023
- Report Format: PDF
Monoclonal Antibodies Market Size
Monoclonal Antibodies Market size was valued at more than USD 186.6 billion in 2022 and will progress tremendously to reach over USD 609 billion by 2032 at 12.5% CAGR attributing to the increasing prevalence of chronic and infectious diseases, growing research and development activities, high rate of adoption of monoclonal antibodies in the U.S. and Europe
Monoclonal antibodies (mAbs) are referred to the category of proteins having ability to bind to specific cells. These are identical immunoglobulins derived from a single B-cell that recognizes unique binding site on antigen. Due to its specificity to unique epitopes, mAbs are being increasingly used for diagnostic and therapeutic applications for several disease. Currently, large number of monoclonal antibodies are available in the market to treat cancer, cardiovascular diseases, autoimmune diseases, blood disorders, and infectious diseases among others.
| Report Attribute | Details |
|---|---|
| Base Year: | 2022 |
| Monoclonal Antibodies Market Size in 2022: | USD 186.6 Billion |
| Forecast Period: | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR: | 12.5% |
| 2032 Value Projection: | USD 609 Billion |
| Historical Data for: | 2018 to 2022 |
| No. of Pages: | 135 |
| Tables, Charts & Figures: | 238 |
| Segments covered: | Type, Application, End-use, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Monoclonal Antibodies Market Scope
